Moderna Financial News

COVID-19 vaccines that emerged as a beacon of hope in the fight against the deadly virus during the pandemic are back in the news again following a new study that has linked the shots to rare brain, heart and blood disorders, Vaccine, a science journal, reported last week. The journal reported that researchers from the Global Vaccine Data Network—a research arm of the World Health Organization—found that the COVID-19 vaccines aggravated 13 medical conditions that were considered “adverse events of special interest." The study conducted on 99 million vaccinated people from eight countries: Argentina, Australia, Canada, Denmark, Finland, France, New Zealand and Scotland, reported that people who received certain types of mRNA vaccines were found to have a higher risk of myocarditis, which is inflammation of the heart muscle.

Investing.com — U.S. futures retreated Monday, with investors cautious ahead of the release of the key monthly inflation data later in the week, which could determine risk appetite going forward.

Regional banks and vaccine makers were among the few bright spots for short sellers in 2023, as the stock market’s big rally last year delivered the group’s steepest cumulative loss since the depths of the pandemic.

With just three trading days left in 2023, stocks on Wall Street are on track to end the year on an upbeat note with investors growing increasingly optimistic that the Federal Reserve is done with raising interest rates as inflation continues to cool.

Asian shares have churned higher after the Dow Jones Industrial Average climbed to another record high

Investing.com — Main U.S. indexes rose Thursday on optimism for future interest rate cuts following the Federal Reserve’s final policy meeting of the year.

Moderna (NASDAQ:MRNA) shares rose more than 12% today after the company said its vaccine candidate, developed together with Merck (MRK) cuts the risk of skin cancer returning by nearly half.

Pfizer on Wednesday forecast 2024 sales that were as much as $5 billion below Wall Street expectations due mostly to declining demand for COVID vaccines and treatment, driving shares down seven per cent in premarket trading.

Investing.com — U.S. stocks rose Thursday, adding to the previous session’s strong gains after the Federal Reserve signaled interest rate cuts to start next year, helped by a bounce in retail sales.

Wall Street pointed toward gains one day after a powerful rally sent the Dow Jones Industrial Average to a record high as the Federal Reserve indicated that interest rate cuts are likely next year

Casino utan svensk licens  är ett casino med en licens utfärdad av en annan myndighet än den Svenska Spelinspektionen. Att spela casino utan Spelpaus har sedan införandet av den svenska spellagen med tillhörande bonusbegränsningar och 3-sekundersregel ökat årligen i popularitet.

Moderna said on Thursday its 2023 sales would only hit the low end of its previous forecast, reflecting weaker demand for COVID-19 vaccines and its shares plummeted over 16% in early trade.

Investing.com — The Dow closed sharply higher Thursday, buoyed by a slump in Treasury yields ahead of the monthly jobs report due Friday following bets that the Federal Reserve is done raising interest rates.

Investing.com — U.S. futures climbed higher Thursday, as investors took confidence in Fed Chair Jerome Powell’s comments, hoping that U.S. interest rates have now peaked.

By Elizabeth Howcroft

Check out the companies making headlines before the bell.

Shares of Pfizer are falling before the opening bell as the company cut its full-year outlook, citing declining sales of its COVID-19-related products

In this article

U.S. regulators have added another option for fall COVID-19 vaccination, updated shots made by Novavax

The Nobel Prize in Medicine has been awarded to two scientists whose work led to mRNA vaccines against COVID-19

By Michael Erman